Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Steroidogenesis Inhibitors seeks Romanian approval to begin pediatric trial with Anticort

June 1, 1998

New HIV protease inhibitors disclosed by Merck & Co.

May 28, 1998

Ligand files NDA for Panretin gel

May 28, 1998

Neoprobe's ACT shows activity against HIV/AIDS in preclinical studies

May 22, 1998

AIDS vaccine produces immune response but fails to protect against challenge with chimeric SIV

May 21, 1998

New anti-HIV option now available in the U.K.

May 21, 1998

Allergene acquires rights to ALG-889

May 20, 1998

PNU-142721, a more potent NNRTI in development at Pharmacia & Upjohn

May 20, 1998

DEHOP phase II data discussed at Digestive Disease Week

May 20, 1998

Glaxo Wellcome introduces anti-HIV combination product in U.K.

May 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...